In its inaugural year, Sana Symposium serves as the only forum to connect members from three key fields of practice—psychiatry, psychotherapy, and addiction treatment—for 3 days of cutting-edge, expertly crafted psychedelics education.

Together with the world's foremost psychedelic researchers, Sana Symposium is delivering the education you need now in order to be successful when widespread approval comes.

Check out the 2021 Brochure. →

Super Saver Rates expire soon!
Register before July 2 to save $200.

The 2021 agenda will expertly guide you through the preparation, journey, and integration of psychedelic therapies with sessions presented by:

• Kwasi Adusei, DNP, PMHNP
  Co-founder of the Psychedelic Society of Western New York
  
  
• Robin Carhart-Harris, PhD
  Head of Psychedelic Research, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London
  
  
• Rick Doblin, PhD
  Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)
  
  
• Rosalind Watts, PhD
  Clinical Director at Synthesis Institute
  
  
• And more!
  View the full list of exceptional thought leaders. →

Now is your chance to be part of the only clinically focused psychedelics event aimed at preparing clinicians like you for this revolutionary treatment option.

Discover new treatment potential and find hope in the future possibilities of care.

Learn more and register at sanasymposium.com.